If the previous dose caused significant issues, consider extending the current dose period before escalating
Rather than implying clinically relevant fat malabsorption, these shifts are more plausibly interpreted as alterations in bile acid signaling and metabolic handling of nutrients that may complement the appetite-suppressive and insulin-sensitizing actions of GLP-1 RAs (86, 87)
The HR for NAION among new users of semaglutide was not different compared with that of the non-GLP-1 receptor agonist drugs using the sensitive NAION definitionempagliflozin (HR: 1.44), sitagliptin (HR: 1.30), and glipizide (HR: 1.23)
GLP-3 RT is used in preclinical research on triple-agonist incretin pharmacology, energy expenditure and thermogenesis, hepatic lipid metabolism, body composition partitioning, and glucose homeostasis
If you or a loved one has suffered serious harm after taking Ozempic, Wegovy, Mounjaro, or another GLP-1 medication , we want to hear from you